,index,gene,pagerank_score,source_disease,ensembl_gene_id,druggability_tier,hgnc_names,chr_b37,start_b37,end_b37,strand,description,no_of_gwas_regions,small_mol_druggable,bio_druggable,adme_gene
0,0,FYN,0.0564525804200281,PD,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
0,0,FYN,0.0564525804200281,Schizophrenia,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,1.0,1.0
1,1,CXCR4,0.0198942424528421,MS,ENSG00000121966,Tier 1,CXCR4,2,136871919.0,136875735.0,-1.0,chemokine (C-X-C motif) receptor 4 [Source:HGNC Symbol;Acc:2561],0.0,1.0,1.0,1.0
2,2,STAT3,0.019722984222456,MS,ENSG00000168610,Tier 1,STAT3,17,40465342.0,40540586.0,-1.0,signal transducer and activator of transcription 3 (acute-phase response factor) [Source:HGNC Symbol;Acc:11364],6.0,1.0,1.0,1.0
3,3,TNFRSF1A,0.0124572730330199,MS,ENSG00000067182,Tier 1,TNFRSF1A,12,6437923.0,6451280.0,-1.0,"tumor necrosis factor receptor superfamily, member 1A [Source:HGNC Symbol;Acc:11916]",3.0,1.0,1.0,1.0
4,4,BMPR1B,0.0095887452384463,Schizophrenia,ENSG00000138696,Tier 1,BMPR1B,4,95679119.0,96079599.0,1.0,"bone morphogenetic protein receptor, type IB [Source:HGNC Symbol;Acc:1077]",0.0,1.0,1.0,1.0
5,5,LRP1,0.0086517878259959,MigraineDisorder,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
5,5,LRP1,0.0086517878259959,MigraineWithAura,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
5,5,LRP1,0.0086517878259959,Schizophrenia,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,1.0,1.0,1.0
6,6,ITGB5,0.0086426552821295,MigraineDisorder,ENSG00000082781,Tier 1,ITGB5,3,124480795.0,124620265.0,-1.0,"integrin, beta 5 [Source:HGNC Symbol;Acc:6160]",0.0,1.0,1.0,1.0
7,7,NGF,0.0081797839501774,MigraineDisorder,ENSG00000134259,Tier 1,NGF,1,115828539.0,115880857.0,-1.0,nerve growth factor (beta polypeptide) [Source:HGNC Symbol;Acc:7808],0.0,1.0,1.0,1.0
8,8,RELN,0.0079996841582723,PartialEpilepsy,ENSG00000189056,Tier 3A,RELN,7,103112231.0,103629963.0,-1.0,reelin [Source:HGNC Symbol;Acc:9957],1.0,1.0,1.0,1.0
9,9,DPP4,0.0077338368495669,Schizophrenia,ENSG00000197635,Tier 1,DPP4,2,162848751.0,162931052.0,-1.0,dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009],2.0,1.0,1.0,1.0
10,10,SNCA,0.0076904934011844,LBD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
10,10,SNCA,0.0076904934011844,PD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,1.0
11,11,NRP1,0.0073227245863569,MigraineDisorder,ENSG00000099250,Tier 1,NRP1,10,33466420.0,33625190.0,-1.0,neuropilin 1 [Source:HGNC Symbol;Acc:8004],0.0,1.0,1.0,1.0
12,12,ITGA9,0.0072650043092857,ALS,ENSG00000144668,Tier 3A,ITGA9,3,37493606.0,37865005.0,1.0,"integrin, alpha 9 [Source:HGNC Symbol;Acc:6145]",3.0,1.0,1.0,1.0
13,13,ACVR1B,0.0070925908273591,MajorDepressiveDisorder,ENSG00000135503,Tier 1,ACVR1B,12,52345451.0,52390862.0,1.0,"activin A receptor, type IB [Source:HGNC Symbol;Acc:172]",0.0,1.0,1.0,1.0
14,14,IL6R,0.0069193387035759,AD,ENSG00000160712,Tier 1,IL6R,1,154377669.0,154441926.0,1.0,interleukin 6 receptor [Source:HGNC Symbol;Acc:6019],9.0,1.0,1.0,1.0
15,15,TLR4,0.0067728234026778,NeuroticDisorder,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,1.0
15,15,TLR4,0.0067728234026778,UnipolarDepression,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,1.0
16,16,IFNGR2,0.0065465353319326,MS,ENSG00000159128,Tier 1,IFNGR2,21,34775202.0,34851655.0,1.0,interferon gamma receptor 2 (interferon gamma transducer 1) [Source:HGNC Symbol;Acc:5440],2.0,1.0,1.0,1.0
17,17,EFNA5,0.0061021344814975,BipolarDisorder,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
17,17,EFNA5,0.0061021344814975,Schizophrenia,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
17,17,EFNA5,0.0061021344814975,UnipolarDepression,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,1.0,1.0,1.0
18,18,CRH,0.005912369293855,PartialEpilepsy,ENSG00000147571,Tier 3B,CRH,8,67088620.0,67090960.0,-1.0,corticotropin releasing hormone [Source:HGNC Symbol;Acc:2355],0.0,1.0,1.0,1.0
19,19,ITGA8,0.0059003994423237,PD,ENSG00000077943,Tier 3A,ITGA8,10,15555948.0,15762124.0,-1.0,"integrin, alpha 8 [Source:HGNC Symbol;Acc:6144]",0.0,1.0,1.0,1.0
20,20,LEPR,0.0051833331032399,Schizophrenia,ENSG00000116678,Tier 3A,LEPR,1,65886248.0,66107242.0,1.0,leptin receptor [Source:HGNC Symbol;Acc:6554],8.0,1.0,1.0,1.0
21,21,APOB,0.0051141324849353,AD,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,1.0
21,21,APOB,0.0051141324849353,BipolarDisorder,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,1.0
22,22,WNT4,0.0050673455714935,Schizophrenia,ENSG00000162552,Tier 3A,WNT4,1,22443798.0,22470462.0,-1.0,"wingless-type MMTV integration site family, member 4 [Source:HGNC Symbol;Acc:12783]",11.0,1.0,1.0,1.0
23,23,IL7R,0.004993666387761,MS,ENSG00000168685,Tier 3A,IL7R,5,35852797.0,35879705.0,1.0,interleukin 7 receptor [Source:HGNC Symbol;Acc:6024],4.0,1.0,1.0,1.0
24,24,IL12A,0.0049402669768785,MS,ENSG00000168811,Tier 3A,IL12A,3,159706537.0,159713806.0,1.0,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [Source:HGNC Symbol;Acc:5969]",2.0,1.0,1.0,1.0
26,26,ERBB4,0.004907657524283,ALS,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
26,26,ERBB4,0.004907657524283,FrontotemporalDementia,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
26,26,ERBB4,0.004907657524283,MajorDepressiveDisorder,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
26,26,ERBB4,0.004907657524283,UnipolarDepression,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,1.0
27,27,GAL,0.0045368784282019,PartialEpilepsy,ENSG00000069482,Tier 3B,GAL,11,68451247.0,68458643.0,1.0,galanin/GMAP prepropeptide [Source:HGNC Symbol;Acc:4114],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,AnorexiaNervosa,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,BipolarDisorder,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,OCD,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,Schizophrenia,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,TouretteSyndrome,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
28,28,PTN,0.0045182148253269,UnipolarDepression,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,1.0,1.0,1.0
29,29,PTK2B,0.0045174981713164,AD,ENSG00000120899,Tier 1,PTK2B,8,27168999.0,27316903.0,1.0,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:9612],1.0,1.0,1.0,1.0
30,30,CALCB,0.0044123616970599,MigraineDisorder,ENSG00000175868,Tier 3A,CALCB,11,14926543.0,15103888.0,1.0,calcitonin-related polypeptide beta [Source:HGNC Symbol;Acc:1438],4.0,1.0,1.0,1.0
31,31,NECTIN2,0.0043939023089224,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
31,31,NECTIN2,0.0043939023089224,PD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
32,32,ESR1,0.0043896533176271,UnipolarDepression,ENSG00000091831,Tier 1,ESR1,6,151977826.0,152450754.0,1.0,estrogen receptor 1 [Source:HGNC Symbol;Acc:3467],14.0,1.0,1.0,1.0
33,33,NRXN1,0.004305362768983,Schizophrenia,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
33,33,NRXN1,0.004305362768983,UnipolarDepression,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,AD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,LBD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
34,34,APOE,0.0040915853088913,PD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,1.0,1.0,1.0
36,36,NOTCH3,0.0039897704734317,MigraineDisorder,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,1.0,1.0,1.0
36,36,NOTCH3,0.0039897704734317,MigraineWithAura,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,1.0,1.0,1.0
37,37,FGF20,0.0038185720603465,PD,ENSG00000078579,Tier 3B,FGF20,8,16849678.0,16859690.0,-1.0,fibroblast growth factor 20 [Source:HGNC Symbol;Acc:3677],0.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,MigraineDisorder,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,MigraineWithAura,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
38,38,STAT6,0.0037889419829804,Schizophrenia,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,1.0,1.0
39,39,CNTN1,0.0037377451179535,PD,ENSG00000018236,Tier 3A,CNTN1,12,41086244.0,41466220.0,1.0,contactin 1 [Source:HGNC Symbol;Acc:2171],1.0,1.0,1.0,1.0
40,40,FGF6,0.0036079353022027,MigraineDisorder,ENSG00000111241,Tier 3B,FGF6,12,4537321.0,4554780.0,-1.0,fibroblast growth factor 6 [Source:HGNC Symbol;Acc:3684],0.0,1.0,1.0,1.0
41,41,APP,0.0034884788088614,AD,ENSG00000142192,Tier 1,APP,21,27252861.0,27543446.0,-1.0,amyloid beta (A4) precursor protein [Source:HGNC Symbol;Acc:620],0.0,1.0,1.0,1.0
42,42,PILRA,0.0034330640184512,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
43,43,WNT7B,0.0034242043216302,BipolarDisorder,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,1.0,1.0,1.0
43,43,WNT7B,0.0034242043216302,MajorDepressiveDisorder,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,1.0,1.0,1.0
43,43,WNT7B,0.0034242043216302,Schizophrenia,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,1.0,1.0,1.0
43,43,WNT7B,0.0034242043216302,UnipolarDepression,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,1.0,1.0,1.0
44,44,WNT3,0.003421010713609,PD,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,1.0
44,44,WNT3,0.003421010713609,Schizophrenia,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,1.0
46,46,TGFB1,0.0032172016648887,MigraineDisorder,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,1.0
47,47,PRKD1,0.0031516901943885,BipolarDisorder,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
47,47,PRKD1,0.0031516901943885,Schizophrenia,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,1.0,1.0
48,48,DCC,0.0031509448493008,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,NeuroticDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,TouretteSyndrome,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
48,48,DCC,0.0031509448493008,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
49,49,FSTL5,0.0030691608214842,BipolarDisorder,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,1.0,1.0,1.0
49,49,FSTL5,0.0030691608214842,UnipolarDepression,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,1.0,1.0,1.0
52,52,CSF2RB,0.0028546914717894,MS,ENSG00000100368,Tier 3A,CSF2RB,22,37309670.0,37336491.0,1.0,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) [Source:HGNC Symbol;Acc:2436]",0.0,1.0,1.0,1.0
53,53,MAP3K14,0.0028363364896286,MS,ENSG00000006062,Tier 2,MAP3K14,17,43340488.0,43394414.0,-1.0,mitogen-activated protein kinase kinase kinase 14 [Source:HGNC Symbol;Acc:6853],0.0,1.0,1.0,1.0
54,54,TGFBR2,0.0028034468274446,MigraineDisorder,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,1.0
54,54,TGFBR2,0.0028034468274446,Schizophrenia,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,1.0
55,55,PDCD1,0.0027627921076626,BrainAneurysm,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,1.0,1.0,1.0
55,55,PDCD1,0.0027627921076626,MS,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,1.0,1.0,1.0
56,56,ADCY1,0.0027447420232005,BipolarDisorder,ENSG00000164742,Tier 1,ADCY1,7,45613739.0,45762715.0,1.0,adenylate cyclase 1 (brain) [Source:HGNC Symbol;Acc:232],0.0,1.0,1.0,1.0
56,56,ADCY1,0.0027447420232005,Schizophrenia,ENSG00000164742,Tier 1,ADCY1,7,45613739.0,45762715.0,1.0,adenylate cyclase 1 (brain) [Source:HGNC Symbol;Acc:232],0.0,1.0,1.0,1.0
57,57,IL2RA,0.0027116841073674,MS,ENSG00000134460,Tier 1,IL2RA,10,6052652.0,6104288.0,-1.0,"interleukin 2 receptor, alpha [Source:HGNC Symbol;Acc:6008]",16.0,1.0,1.0,1.0
58,58,TNFSF14,0.0026762637078537,MS,ENSG00000125735,Tier 1,TNFSF14,19,6663148.0,6670599.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 14 [Source:HGNC Symbol;Acc:11930]",1.0,1.0,1.0,1.0
59,59,GFRA2,0.0026441107927064,FrontotemporalDementia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
60,60,FGFR3,0.0025105997278826,PartialEpilepsy,ENSG00000068078,Tier 1,FGFR3,4,1795034.0,1810599.0,1.0,fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:3690],0.0,1.0,1.0,1.0
61,61,PTPRD,0.0025014303887451,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
62,62,SEMA3A,0.0024339543724975,UnipolarDepression,ENSG00000075213,Tier 3A,SEMA3A,7,83585093.0,84122040.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A [Source:HGNC Symbol;Acc:10723]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,AnorexiaNervosa,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,BipolarDisorder,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,OCD,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,Schizophrenia,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,TouretteSyndrome,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
64,64,GRIA1,0.0023871392248264,UnipolarDepression,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,MS,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
66,66,CD40,0.0022628513885853,UnipolarDepression,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,1.0,1.0,1.0
67,67,TGFBR3,0.0022017508990382,MS,ENSG00000069702,Tier 3A,TGFBR3,1,92145902.0,92371892.0,-1.0,"transforming growth factor, beta receptor III [Source:HGNC Symbol;Acc:11774]",0.0,1.0,1.0,1.0
68,68,CD47,0.0021956047071088,BipolarDisorder,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,1.0,1.0,1.0
68,68,CD47,0.0021956047071088,TouretteSyndrome,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,1.0,1.0,1.0
71,71,DSCAM,0.0021444762325549,BrainAneurysm,ENSG00000171587,Tier 3A,DSCAM,21,41382926.0,42219065.0,-1.0,Down syndrome cell adhesion molecule [Source:HGNC Symbol;Acc:3039],0.0,1.0,1.0,1.0
72,72,NOS1,0.0021380353411536,NeuroticDisorder,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,1.0,1.0
72,72,NOS1,0.0021380353411536,Schizophrenia,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,1.0,1.0
72,72,NOS1,0.0021380353411536,UnipolarDepression,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,AnorexiaNervosa,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,BipolarDisorder,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,OCD,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,Schizophrenia,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,TouretteSyndrome,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
73,73,NMB,0.0021339357771717,UnipolarDepression,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,1.0,1.0,1.0
74,74,GRN,0.0021229543956907,AD,ENSG00000030582,Tier 3A,GRN,17,42422614.0,42430470.0,1.0,granulin [Source:HGNC Symbol;Acc:4601],1.0,1.0,1.0,1.0
74,74,GRN,0.0021229543956907,FrontotemporalDementia,ENSG00000030582,Tier 3A,GRN,17,42422614.0,42430470.0,1.0,granulin [Source:HGNC Symbol;Acc:4601],1.0,1.0,1.0,1.0
77,77,EPHA1,0.002015546956161,AD,ENSG00000146904,Tier 1,EPHA1,7,143087382.0,143105985.0,-1.0,EPH receptor A1 [Source:HGNC Symbol;Acc:3385],1.0,1.0,1.0,1.0
78,78,S1PR1,0.0020122497509774,PD,ENSG00000170989,Tier 1,S1PR1,1,101702444.0,101707074.0,1.0,sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:3165],0.0,1.0,1.0,1.0
79,79,NLGN1,0.0019972652496757,UnipolarDepression,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,1.0,1.0
80,80,PTCH1,0.0019897518540602,NeuroticDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
80,80,PTCH1,0.0019897518540602,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
82,82,ROBO2,0.0019810461313688,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
82,82,ROBO2,0.0019810461313688,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
83,83,MAPK1,0.0019757453465736,MS,ENSG00000100030,Tier 1,MAPK1,22,22108789.0,22221970.0,-1.0,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:6871],1.0,1.0,1.0,1.0
84,84,EDNRA,0.0019585194335442,BrainAneurysm,ENSG00000151617,Tier 1,EDNRA,4,148402069.0,148466106.0,1.0,endothelin receptor type A [Source:HGNC Symbol;Acc:3179],2.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,PD,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,Schizophrenia,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
85,85,CRHR1,0.0019415432379518,UnipolarDepression,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,1.0
86,86,MAPK3,0.0019319519926951,MS,ENSG00000102882,Tier 1,MAPK3,16,30125426.0,30134827.0,-1.0,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:6877],1.0,1.0,1.0,1.0
89,89,MAP4K4,0.0018565881997868,PD,ENSG00000071054,Tier 1,MAP4K4,2,102313312.0,102511149.0,1.0,mitogen-activated protein kinase kinase kinase kinase 4 [Source:HGNC Symbol;Acc:6866],0.0,1.0,1.0,1.0
90,90,LRIG1,0.0018514117335486,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
93,93,MPO,0.0017534738135553,AD,ENSG00000005381,Tier 1,MPO,17,56347217.0,56358296.0,-1.0,myeloperoxidase [Source:HGNC Symbol;Acc:7218],1.0,1.0,1.0,1.0
94,94,TYK2,0.0017357842542778,MS,ENSG00000105397,Tier 1,TYK2,19,10461209.0,10491352.0,-1.0,tyrosine kinase 2 [Source:HGNC Symbol;Acc:12440],7.0,1.0,1.0,1.0
95,95,EPHA5,0.001722843360162,Schizophrenia,ENSG00000145242,Tier 1,EPHA5,4,66185281.0,66536213.0,-1.0,EPH receptor A5 [Source:HGNC Symbol;Acc:3389],0.0,1.0,1.0,1.0
96,96,ADGRV1,0.001708962947054,EssentialTremor,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
96,96,ADGRV1,0.001708962947054,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,RestlessLeg,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
97,97,SEMA6D,0.0016896310719371,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
98,98,SLIT3,0.0016827495435608,BipolarDisorder,ENSG00000184347,Tier 3A,SLIT3,5,168088745.0,168728133.0,-1.0,slit homolog 3 (Drosophila) [Source:HGNC Symbol;Acc:11087],3.0,1.0,1.0,1.0
100,100,PLCB1,0.0016756594928024,PartialEpilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
102,102,NID1,0.0016467865464167,PartialEpilepsy,ENSG00000116962,Tier 3A,NID1,1,236139130.0,236228462.0,-1.0,nidogen 1 [Source:HGNC Symbol;Acc:7821],0.0,1.0,1.0,1.0
103,103,LGI1,0.0016238849826584,PartialEpilepsy,ENSG00000108231,Tier 3B,LGI1,10,95517566.0,95557916.0,1.0,"leucine-rich, glioma inactivated 1 [Source:HGNC Symbol;Acc:6572]",0.0,1.0,1.0,1.0
104,104,SHANK2,0.0016237607616371,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
104,104,SHANK2,0.0016237607616371,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
105,105,NMUR2,0.0016237607616371,AnorexiaNervosa,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,BipolarDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,MigraineDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,OCD,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,Schizophrenia,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,TouretteSyndrome,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
105,105,NMUR2,0.0016237607616371,UnipolarDepression,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,AnorexiaNervosa,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,BipolarDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,MajorDepressiveDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,OCD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,Schizophrenia,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,TouretteSyndrome,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
106,106,NEGR1,0.0016237607616371,UnipolarDepression,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,1.0,1.0,1.0
108,108,MERTK,0.0016198489337558,MS,ENSG00000153208,Tier 1,MERTK,2,112656056.0,112787138.0,1.0,c-mer proto-oncogene tyrosine kinase [Source:HGNC Symbol;Acc:7027],2.0,1.0,1.0,1.0
110,110,PTPRG,0.0016161984905377,AD,ENSG00000144724,Tier 3A,PTPRG,3,61547243.0,62283288.0,1.0,"protein tyrosine phosphatase, receptor type, G [Source:HGNC Symbol;Acc:9671]",0.0,1.0,1.0,1.0
116,116,IL2,0.0015189006191819,BipolarDisorder,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
116,116,IL2,0.0015189006191819,UnipolarDepression,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,1.0,1.0,1.0
118,118,PLXNA4,0.0014785298068369,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
118,118,PLXNA4,0.0014785298068369,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
121,121,SYNJ1,0.0014667311657548,PD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
123,123,ATM,0.0014467884971252,PD,ENSG00000149311,Tier 2,ATM,11,108093211.0,108239829.0,1.0,ataxia telangiectasia mutated [Source:HGNC Symbol;Acc:795],3.0,1.0,1.0,1.0
124,124,CSF1R,0.0014175869226407,AD,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,1.0
124,124,CSF1R,0.0014175869226407,FrontotemporalDementia,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,1.0
124,124,CSF1R,0.0014175869226407,PD,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,AnorexiaNervosa,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,BipolarDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,OCD,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,PartialEpilepsy,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,Schizophrenia,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,TouretteSyndrome,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
125,125,GRIN2A,0.0014168017559012,UnipolarDepression,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,1.0,1.0
126,126,SCN9A,0.001413367786044,PartialEpilepsy,ENSG00000169432,Tier 1,SCN9A,2,167051695.0,167232503.0,-1.0,"sodium channel, voltage-gated, type IX, alpha subunit [Source:HGNC Symbol;Acc:10597]",0.0,1.0,1.0,1.0
127,127,ERBB2,0.001408421691752,BipolarDisorder,ENSG00000141736,Tier 1,ERBB2,17,37844167.0,37886679.0,1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 [Source:HGNC Symbol;Acc:3430],3.0,1.0,1.0,1.0
130,130,CLEC2D,0.001398716244002,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
131,131,DCLK3,0.0013733067671411,AnorexiaNervosa,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,BipolarDisorder,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,OCD,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,Schizophrenia,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,TouretteSyndrome,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
131,131,DCLK3,0.0013733067671411,UnipolarDepression,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,AnorexiaNervosa,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,BipolarDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,MajorDepressiveDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,OCD,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,Schizophrenia,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,TouretteSyndrome,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
133,133,FES,0.001366834331152,UnipolarDepression,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,AnorexiaNervosa,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,BipolarDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,OCD,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,Schizophrenia,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,TouretteSyndrome,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
135,135,CNTN4,0.0013659009016166,UnipolarDepression,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,1.0,1.0,1.0
136,136,CSF3,0.0013639278870781,BipolarDisorder,ENSG00000108342,Tier 3A,CSF3,17,38171614.0,38174066.0,1.0,colony stimulating factor 3 (granulocyte) [Source:HGNC Symbol;Acc:2438],8.0,1.0,1.0,1.0
138,138,TREM2,0.0013627890688531,FrontotemporalDementia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
139,139,CHRNA7,0.0013583774784594,PartialEpilepsy,ENSG00000175344,Tier 1,CHRNA7,15,32322691.0,32464722.0,1.0,"cholinergic receptor, nicotinic, alpha 7 (neuronal) [Source:HGNC Symbol;Acc:1960]",0.0,1.0,1.0,1.0
142,142,MMP3,0.0013529973029418,AD,ENSG00000149968,Tier 1,MMP3,11,102706532.0,102714534.0,-1.0,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Source:HGNC Symbol;Acc:7173]",7.0,1.0,1.0,1.0
144,144,ABCB1,0.0013441201371739,Schizophrenia,ENSG00000085563,Tier 1,ABCB1,7,87133175.0,87342611.0,-1.0,"ATP-binding cassette, sub-family B (MDR/TAP), member 1 [Source:HGNC Symbol;Acc:40]",0.0,1.0,1.0,1.0
145,145,INPP5D,0.0013432831408133,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
147,147,CD33,0.0013371602639826,AD,ENSG00000105383,Tier 1,CD33,19,51728320.0,51747115.0,1.0,CD33 molecule [Source:HGNC Symbol;Acc:1659],1.0,1.0,1.0,1.0
154,154,CD86,0.0012899747936994,MS,ENSG00000114013,Tier 1,CD86,3,121774213.0,121839983.0,1.0,CD86 molecule [Source:HGNC Symbol;Acc:1705],1.0,1.0,1.0,1.0
155,155,PLA2G6,0.001288065530286,PD,ENSG00000184381,Tier 2,PLA2G6,22,38507502.0,38601697.0,-1.0,"phospholipase A2, group VI (cytosolic, calcium-independent) [Source:HGNC Symbol;Acc:9039]",4.0,1.0,1.0,1.0
158,158,PLCG2,0.001264902704501,AD,ENSG00000197943,Tier 2,PLCG2,16,81772702.0,81991899.0,1.0,"phospholipase C, gamma 2 (phosphatidylinositol-specific) [Source:HGNC Symbol;Acc:9066]",0.0,1.0,1.0,1.0
159,159,FCGR2A,0.0012190366473683,PD,ENSG00000143226,Tier 3A,FCGR2A,1,161475220.0,161493803.0,1.0,"Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616]",6.0,1.0,1.0,1.0
162,162,CALCA,0.0012032627541918,MigraineDisorder,ENSG00000110680,Tier 1,CALCA,11,14988214.0,14993900.0,-1.0,calcitonin-related polypeptide alpha [Source:HGNC Symbol;Acc:1437],0.0,1.0,1.0,1.0
163,163,PDGFRB,0.0011987482089792,PD,ENSG00000113721,Tier 1,PDGFRB,5,149493400.0,149535435.0,-1.0,"platelet-derived growth factor receptor, beta polypeptide [Source:HGNC Symbol;Acc:8804]",0.0,1.0,1.0,1.0
170,170,CD226,0.0011375647049817,MS,ENSG00000150637,Tier 3A,CD226,18,67498394.0,67629039.0,-1.0,CD226 molecule [Source:HGNC Symbol;Acc:16961],7.0,1.0,1.0,1.0
177,177,SCN1A,0.001120664190045,MigraineDisorder,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
177,177,SCN1A,0.001120664190045,MigraineWithAura,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
177,177,SCN1A,0.001120664190045,PartialEpilepsy,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,1.0,1.0
178,178,SCN3A,0.001120664190045,BipolarDisorder,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,1.0,1.0
178,178,SCN3A,0.001120664190045,PartialEpilepsy,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,1.0,1.0
178,178,SCN3A,0.001120664190045,PD,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,1.0,1.0
179,179,SCN2A,0.001120664190045,BipolarDisorder,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
179,179,SCN2A,0.001120664190045,PartialEpilepsy,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
179,179,SCN2A,0.001120664190045,PD,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,1.0,1.0
183,183,SORL1,0.0011135857461024,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
184,184,MAPT,0.0011135857461024,AD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,FrontotemporalDementia,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,NeuroticDisorder,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,PD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
184,184,MAPT,0.0011135857461024,ProgressiveSupranuclearPalsy,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,1.0,1.0
186,186,SLC6A4,0.0011135857461024,OCD,ENSG00000108576,Tier 1,SLC6A4,17,28521337.0,28563020.0,-1.0,"solute carrier family 6 (neurotransmitter transporter), member 4 [Source:HGNC Symbol;Acc:11050]",1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,EssentialTremor,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,NeuroticDisorder,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,Schizophrenia,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
187,187,LINGO1,0.0011135857461024,UnipolarDepression,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,1.0,1.0,1.0
190,190,VANGL2,0.0011135857461024,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
191,191,CD58,0.0011028707332872,MS,ENSG00000116815,Tier 3A,CD58,1,117057157.0,117113661.0,-1.0,CD58 molecule [Source:HGNC Symbol;Acc:1688],3.0,1.0,1.0,1.0
194,194,EDAR,0.0010823951081325,AD,ENSG00000135960,Tier 3A,EDAR,2,109510927.0,109605828.0,-1.0,ectodysplasin A receptor [Source:HGNC Symbol;Acc:2895],0.0,1.0,1.0,1.0
195,195,SLITRK1,0.0010822940544543,TouretteSyndrome,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
196,196,CD6,0.0010803195384759,MS,ENSG00000013725,Tier 1,CD6,11,60739115.0,60787849.0,1.0,CD6 molecule [Source:HGNC Symbol;Acc:1691],3.0,1.0,1.0,1.0
198,198,LRFN5,0.0010703281086749,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,MajorDepressiveDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,OCD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,TouretteSyndrome,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
198,198,LRFN5,0.0010703281086749,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
204,204,PTPRF,0.0010429659664337,AnorexiaNervosa,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,BipolarDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,OCD,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,Schizophrenia,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,TouretteSyndrome,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
204,204,PTPRF,0.0010429659664337,UnipolarDepression,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,1.0,1.0
212,212,LCK,0.0010094948731558,MS,ENSG00000182866,Tier 1,LCK,1,32716840.0,32751766.0,1.0,lymphocyte-specific protein tyrosine kinase [Source:HGNC Symbol;Acc:6524],0.0,1.0,1.0,1.0
217,217,BCL6,0.0009969677425211,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
219,219,SLC2A1,0.0009875051447986,MigraineDisorder,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,1.0,1.0
219,219,SLC2A1,0.0009875051447986,PartialEpilepsy,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,1.0,1.0
225,225,IL22RA2,0.0009536241158102,MS,ENSG00000164485,Tier 3A,IL22RA2,6,137464968.0,137494785.0,-1.0,"interleukin 22 receptor, alpha 2 [Source:HGNC Symbol;Acc:14901]",0.0,1.0,1.0,1.0
226,226,LPP,0.0009523660633633,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
226,226,LPP,0.0009523660633633,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
227,227,CHRNA4,0.0009516171387573,ALS,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
227,227,CHRNA4,0.0009516171387573,FrontotemporalDementia,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
227,227,CHRNA4,0.0009516171387573,PartialEpilepsy,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,1.0,1.0
229,229,CR1,0.0009487397404435,AD,ENSG00000203710,Tier 3A,CR1,1,207669492.0,207813992.0,1.0,complement component (3b/4b) receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:2334],8.0,1.0,1.0,1.0
231,231,JAK1,0.0009482063598069,MS,ENSG00000162434,Tier 1,JAK1,1,65298912.0,65432187.0,-1.0,Janus kinase 1 [Source:HGNC Symbol;Acc:6190],0.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,AnorexiaNervosa,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,BipolarDisorder,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,OCD,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,Schizophrenia,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,TouretteSyndrome,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
235,235,EP300,0.0009407362444548,UnipolarDepression,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,1.0,1.0
236,236,HGF,0.0009400191865102,AD,ENSG00000019991,Tier 1,HGF,7,81328322.0,81399754.0,-1.0,hepatocyte growth factor (hepapoietin A; scatter factor) [Source:HGNC Symbol;Acc:4893],0.0,1.0,1.0,1.0
237,237,ACE,0.0009372097661254,AD,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
237,237,ACE,0.0009372097661254,IntracranialHemorrhage,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,1.0
238,238,CTSB,0.0009367857900797,PD,ENSG00000164733,Tier 1,CTSB,8,11700033.0,11726957.0,-1.0,cathepsin B [Source:HGNC Symbol;Acc:2527],0.0,1.0,1.0,1.0
239,239,PLXNC1,0.0009336909799716,MS,ENSG00000136040,Tier 3B,PLXNC1,12,94542499.0,94701451.0,1.0,plexin C1 [Source:HGNC Symbol;Acc:9106],0.0,1.0,1.0,1.0
241,241,SCARB1,0.0009274888946892,AD,ENSG00000073060,Tier 2,SCARB1,12,125261402.0,125367214.0,-1.0,"scavenger receptor class B, member 1 [Source:HGNC Symbol;Acc:1664]",6.0,1.0,1.0,1.0
244,244,IL12B,0.0009177789993131,MS,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
244,244,IL12B,0.0009177789993131,UnipolarDepression,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,1.0,1.0,1.0
251,251,STK39,0.000892945607934,PD,ENSG00000198648,Tier 2,STK39,2,168810530.0,169104651.0,-1.0,serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717],2.0,1.0,1.0,1.0
252,252,GPR151,0.0008906399590804,EssentialTremor,ENSG00000173250,Tier 3B,GPR151,5,145892666.0,145895753.0,-1.0,G protein-coupled receptor 151 [Source:HGNC Symbol;Acc:23624],0.0,1.0,1.0,1.0
257,257,GRIN1,0.0008601330786802,PartialEpilepsy,ENSG00000176884,Tier 1,GRIN1,9,140032842.0,140063207.0,1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 1 [Source:HGNC Symbol;Acc:4584]",0.0,1.0,1.0,1.0
259,259,BTN1A1,0.0008584982383351,BipolarDisorder,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,1.0,1.0,1.0
259,259,BTN1A1,0.0008584982383351,UnipolarDepression,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,1.0,1.0,1.0
262,262,ADGRL2,0.0008584982383351,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
263,263,ADGRL1,0.0008584982383351,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
272,272,BMP3,0.0008436652451172,Schizophrenia,ENSG00000152785,Tier 3A,BMP3,4,81952119.0,81978685.0,1.0,bone morphogenetic protein 3 [Source:HGNC Symbol;Acc:1070],0.0,1.0,1.0,1.0
287,287,BMP8A,0.0008060544202762,MigraineDisorder,ENSG00000183682,Tier 3A,BMP8A,1,39957318.0,39991607.0,1.0,bone morphogenetic protein 8a [Source:HGNC Symbol;Acc:21650],4.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,AnorexiaNervosa,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,BipolarDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,MajorDepressiveDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,OCD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,Schizophrenia,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,TouretteSyndrome,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
288,288,ESR2,0.0008046497388912,UnipolarDepression,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,1.0,1.0
305,305,LAMB3,0.0007902657600448,ALS,ENSG00000196878,Tier 1,LAMB3,1,209788215.0,209825811.0,-1.0,"laminin, beta 3 [Source:HGNC Symbol;Acc:6490]",0.0,1.0,1.0,1.0
313,313,PLCE1,0.0007817483612876,BrainAneurysm,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
313,313,PLCE1,0.0007817483612876,MigraineDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
329,329,CD28,0.000759695350571,MS,ENSG00000178562,Tier 1,CD28,2,204571198.0,204603635.0,1.0,CD28 molecule [Source:HGNC Symbol;Acc:1653],2.0,1.0,1.0,1.0
330,330,IL34,0.0007587237410397,AD,ENSG00000157368,Tier 3B,IL34,16,70613798.0,70694585.0,1.0,interleukin 34 [Source:HGNC Symbol;Acc:28529],0.0,1.0,1.0,1.0
332,332,ANG,0.000756956621707,ALS,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,1.0,1.0,1.0
332,332,ANG,0.000756956621707,FrontotemporalDementia,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,AnorexiaNervosa,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,BipolarDisorder,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,OCD,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,Schizophrenia,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,TouretteSyndrome,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
346,346,GPR20,0.0007522209707979,UnipolarDepression,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,1.0
349,349,SEMA3B,0.0007520454294001,NeuroticDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
358,358,CAMK2D,0.0007485106339753,PD,ENSG00000145349,Tier 1,CAMK2D,4,114372188.0,114683083.0,-1.0,calcium/calmodulin-dependent protein kinase II delta [Source:HGNC Symbol;Acc:1462],1.0,1.0,1.0,1.0
364,364,GPC5,0.0007475946536792,Schizophrenia,ENSG00000179399,Tier 3A,GPC5,13,92050929.0,93519490.0,1.0,glypican 5 [Source:HGNC Symbol;Acc:4453],3.0,1.0,1.0,1.0
367,367,SLAMF1,0.0007454149850987,MS,ENSG00000117090,Tier 3A,SLAMF1,1,160577890.0,160617085.0,-1.0,signaling lymphocytic activation molecule family member 1 [Source:HGNC Symbol;Acc:10903],0.0,1.0,1.0,1.0
380,380,ITGB7,0.0007317620585544,Schizophrenia,ENSG00000139626,Tier 1,ITGB7,12,53585102.0,53601091.0,-1.0,"integrin, beta 7 [Source:HGNC Symbol;Acc:6162]",0.0,1.0,1.0,1.0
394,394,IL21,0.0007245077367681,BipolarDisorder,ENSG00000138684,Tier 3A,IL21,4,123533783.0,123542224.0,-1.0,interleukin 21 [Source:HGNC Symbol;Acc:6005],9.0,1.0,1.0,1.0
396,396,SMPD3,0.0007226561239666,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
403,403,PDGFD,0.000713946391875,MigraineDisorder,ENSG00000170962,Tier 3A,PDGFD,11,103777914.0,104035107.0,-1.0,platelet derived growth factor D [Source:HGNC Symbol;Acc:30620],0.0,1.0,1.0,1.0
406,406,TBK1,0.0007092890764613,ALS,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,1.0,1.0
406,406,TBK1,0.0007092890764613,FrontotemporalDementia,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,1.0,1.0
410,410,CHRNB2,0.0007031500366622,PartialEpilepsy,ENSG00000160716,Tier 1,CHRNB2,1,154540257.0,154552502.0,1.0,"cholinergic receptor, nicotinic, beta 2 (neuronal) [Source:HGNC Symbol;Acc:1962]",0.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,ALS,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,AnorexiaNervosa,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,BipolarDisorder,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,BrainAneurysm,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,OCD,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,Schizophrenia,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,TouretteSyndrome,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
411,411,CHRNA3,0.0007031500366622,UnipolarDepression,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,ALS,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,AnorexiaNervosa,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,BipolarDisorder,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,FrontotemporalDementia,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
412,412,CHRNB4,0.0007031500366622,Schizophrenia,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,1.0,1.0
413,413,CHRNA2,0.0007031500366622,AD,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
413,413,CHRNA2,0.0007031500366622,PartialEpilepsy,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
413,413,CHRNA2,0.0007031500366622,Schizophrenia,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,1.0
414,414,CD8B,0.0006975964257464,ProgressiveSupranuclearPalsy,ENSG00000172116,Tier 3A,CD8B,2,87042462.0,87089047.0,-1.0,CD8b molecule [Source:HGNC Symbol;Acc:1707],1.0,1.0,1.0,1.0
428,428,HDC,0.0006751972027946,TouretteSyndrome,ENSG00000140287,Tier 2,HDC,15,50534144.0,50558223.0,-1.0,histidine decarboxylase [Source:HGNC Symbol;Acc:4855],0.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,BipolarDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,MajorDepressiveDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,NeuroticDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
432,432,GRM5,0.000649089175245,UnipolarDepression,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,1.0,1.0
434,434,ROBO1,0.0006436471954033,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
435,435,FGFR1,0.0006352084682274,BipolarDisorder,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,1.0
435,435,FGFR1,0.0006352084682274,Schizophrenia,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,1.0
438,438,RTN4R,0.0006274747558969,Schizophrenia,ENSG00000040608,Tier 3A,RTN4R,22,20228938.0,20270769.0,-1.0,reticulon 4 receptor [Source:HGNC Symbol;Acc:18601],0.0,1.0,1.0,1.0
440,440,DAG1,0.0006264769230192,UnipolarDepression,ENSG00000173402,Tier 3B,DAG1,3,49506146.0,49573048.0,1.0,dystroglycan 1 (dystrophin-associated glycoprotein 1) [Source:HGNC Symbol;Acc:2666],11.0,1.0,1.0,1.0
441,441,PMCH,0.0006262461922321,RestlessLeg,ENSG00000183395,Tier 3B,PMCH,12,102590237.0,102591623.0,-1.0,pro-melanin-concentrating hormone [Source:HGNC Symbol;Acc:9109],3.0,1.0,1.0,1.0
462,462,PON1,0.0005682983884667,ALS,ENSG00000005421,Tier 1,PON1,7,94926988.0,95025673.0,-1.0,paraoxonase 1 [Source:HGNC Symbol;Acc:9204],3.0,1.0,1.0,1.0
470,470,LILRA5,0.0005494418709892,AD,ENSG00000187116,Tier 3A,LILRA5,19,54818353.0,54824409.0,-1.0,"leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 [Source:HGNC Symbol;Acc:16309]",0.0,1.0,1.0,1.0
471,471,CD80,0.0005467644876603,MS,ENSG00000121594,Tier 1,CD80,3,119243140.0,119278449.0,-1.0,CD80 molecule [Source:HGNC Symbol;Acc:1700],6.0,1.0,1.0,1.0
481,481,PVR,0.0005408898944529,MS,ENSG00000073008,Tier 3A,PVR,19,45147098.0,45166850.0,1.0,poliovirus receptor [Source:HGNC Symbol;Acc:9705],0.0,1.0,1.0,1.0
486,486,NR1H3,0.0005194064556032,MS,ENSG00000025434,Tier 2,NR1H3,11,47269851.0,47290396.0,1.0,"nuclear receptor subfamily 1, group H, member 3 [Source:HGNC Symbol;Acc:7966]",11.0,1.0,1.0,1.0
487,487,PPARA,0.0005194064556032,BipolarDisorder,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,1.0,1.0
487,487,PPARA,0.0005194064556032,MajorDepressiveDisorder,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,1.0,1.0
487,487,PPARA,0.0005194064556032,Schizophrenia,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,1.0,1.0
487,487,PPARA,0.0005194064556032,UnipolarDepression,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,1.0,1.0
518,518,BMP2,0.0005076674145674,UnipolarDepression,ENSG00000125845,Tier 3A,BMP2,20,6748311.0,6760927.0,1.0,bone morphogenetic protein 2 [Source:HGNC Symbol;Acc:1069],1.0,1.0,1.0,1.0
526,526,JAG1,0.0005065027767996,MigraineDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,1.0,1.0,1.0
527,527,UNC5C,0.000504408726493,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
573,573,IDE,0.0004941124828182,ALS,ENSG00000119912,Tier 2,IDE,10,94211441.0,94333833.0,-1.0,insulin-degrading enzyme [Source:HGNC Symbol;Acc:5381],10.0,1.0,1.0,1.0
574,574,SLC10A2,0.0004941124828182,AD,ENSG00000125255,Tier 1,SLC10A2,13,103696350.0,103719196.0,-1.0,"solute carrier family 10 (sodium/bile acid cotransporter), member 2 [Source:HGNC Symbol;Acc:10906]",0.0,1.0,1.0,1.0
588,588,LTBR,0.0004919183509912,MS,ENSG00000111321,Tier 1,LTBR,12,6484211.0,6500733.0,1.0,"lymphotoxin beta receptor (TNFR superfamily, member 3) [Source:HGNC Symbol;Acc:6718]",1.0,1.0,1.0,1.0
592,592,BTN3A2,0.0004914003997622,BipolarDisorder,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,1.0,1.0,1.0
592,592,BTN3A2,0.0004914003997622,MajorDepressiveDisorder,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,1.0,1.0,1.0
592,592,BTN3A2,0.0004914003997622,Schizophrenia,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,1.0,1.0,1.0
593,593,CNTNAP2,0.0004911184456382,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
593,593,CNTNAP2,0.0004911184456382,PartialEpilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
594,594,TYR,0.0004827707179102,UnipolarDepression,ENSG00000077498,Tier 1,TYR,11,88910620.0,89028927.0,1.0,tyrosinase [Source:HGNC Symbol;Acc:12442],11.0,1.0,1.0,1.0
596,596,HAVCR2,0.0004791571903772,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
602,602,HP,0.0004703028028074,AnorexiaNervosa,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
602,602,HP,0.0004703028028074,BipolarDisorder,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
602,602,HP,0.0004703028028074,OCD,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
602,602,HP,0.0004703028028074,Schizophrenia,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
602,602,HP,0.0004703028028074,TouretteSyndrome,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
602,602,HP,0.0004703028028074,UnipolarDepression,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,AnorexiaNervosa,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,BipolarDisorder,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,OCD,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,Schizophrenia,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,TouretteSyndrome,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
620,620,ATP2A2,0.0004664559360162,UnipolarDepression,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,1.0,1.0
628,628,PAM,0.000466214432254,PD,ENSG00000145730,Tier 2,PAM,5,102089685.0,102366809.0,1.0,peptidylglycine alpha-amidating monooxygenase [Source:HGNC Symbol;Acc:8596],0.0,1.0,1.0,1.0
630,630,ETV5,0.0004661799988689,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
638,638,HBEGF,0.0004652219450999,AD,ENSG00000113070,Tier 1,HBEGF,5,139712428.0,139726216.0,-1.0,heparin-binding EGF-like growth factor [Source:HGNC Symbol;Acc:3059],0.0,1.0,1.0,1.0
641,641,ATP2B1,0.0004647749531563,BrainAneurysm,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
648,648,CDH10,0.0004626361236933,AnorexiaNervosa,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
655,655,MDK,0.0004614288380923,AnorexiaNervosa,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,BipolarDisorder,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,OCD,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,Schizophrenia,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,TouretteSyndrome,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
655,655,MDK,0.0004614288380923,UnipolarDepression,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,1.0,1.0,1.0
662,662,DKK1,0.0004614288380923,Schizophrenia,ENSG00000107984,Tier 1,DKK1,10,54074056.0,54077802.0,1.0,dickkopf WNT signaling pathway inhibitor 1 [Source:HGNC Symbol;Acc:2891],0.0,1.0,1.0,1.0
687,687,TXK,0.0004597414579143,MS,ENSG00000074966,Tier 1,TXK,4,48068410.0,48136273.0,-1.0,TXK tyrosine kinase [Source:HGNC Symbol;Acc:12434],0.0,1.0,1.0,1.0
689,689,TNK2,0.0004597414579143,PD,ENSG00000061938,Tier 1,TNK2,3,195590235.0,195638816.0,-1.0,"tyrosine kinase, non-receptor, 2 [Source:HGNC Symbol;Acc:19297]",0.0,1.0,1.0,1.0
697,697,PTPRJ,0.0004597414579143,AD,ENSG00000149177,Tier 3A,PTPRJ,11,48002113.0,48189670.0,1.0,"protein tyrosine phosphatase, receptor type, J [Source:HGNC Symbol;Acc:9673]",7.0,1.0,1.0,1.0
704,704,TUBA4A,0.0004597414579143,ALS,ENSG00000127824,Tier 3B,TUBA4A,2,220114433.0,220142892.0,-1.0,"tubulin, alpha 4a [Source:HGNC Symbol;Acc:12407]",0.0,1.0,1.0,1.0
705,705,AATK,0.0004597414579143,NeuroticDisorder,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,1.0,1.0
705,705,AATK,0.0004597414579143,UnipolarDepression,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,1.0,1.0
718,718,FLOT1,0.0004597414579143,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
736,736,CD19,0.0004597414579143,PD,ENSG00000177455,Tier 1,CD19,16,28943260.0,28950667.0,1.0,CD19 molecule [Source:HGNC Symbol;Acc:1633],8.0,1.0,1.0,1.0
745,745,CD5,0.0004597414579143,MS,ENSG00000110448,Tier 1,CD5,11,60869867.0,60895324.0,1.0,CD5 molecule [Source:HGNC Symbol;Acc:1685],0.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,AnorexiaNervosa,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,BipolarDisorder,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,OCD,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,Schizophrenia,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,TouretteSyndrome,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
752,752,NOX4,0.0004597414579143,UnipolarDepression,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,1.0,1.0
765,765,MST1R,0.0004597414579143,Schizophrenia,ENSG00000164078,Tier 1,MST1R,3,49924435.0,49941299.0,-1.0,macrophage stimulating 1 receptor (c-met-related tyrosine kinase) [Source:HGNC Symbol;Acc:7381],3.0,1.0,1.0,1.0
767,767,SST,0.0004589733019441,MS,ENSG00000157005,Tier 1,SST,3,187386694.0,187388187.0,-1.0,somatostatin [Source:HGNC Symbol;Acc:11329],0.0,1.0,1.0,1.0
781,781,MAP2K5,0.000456905040935,BipolarDisorder,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,1.0,1.0
781,781,MAP2K5,0.000456905040935,RestlessLeg,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,1.0,1.0
806,806,PRKAG1,0.0004425399982963,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
810,810,VRK2,0.0004410516180627,AnorexiaNervosa,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,BipolarDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,MajorDepressiveDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,OCD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,PartialEpilepsy,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,Schizophrenia,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,TouretteSyndrome,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
810,810,VRK2,0.0004410516180627,UnipolarDepression,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,1.0,1.0
811,811,VRK1,0.0004410516180627,ALS,ENSG00000100749,Tier 3A,VRK1,14,97263641.0,97398059.0,1.0,vaccinia related kinase 1 [Source:HGNC Symbol;Acc:12718],0.0,1.0,1.0,1.0
812,812,PLK2,0.0004410516180627,Schizophrenia,ENSG00000145632,Tier 2,PLK2,5,57749809.0,57756087.0,-1.0,polo-like kinase 2 [Source:HGNC Symbol;Acc:19699],0.0,1.0,1.0,1.0
814,814,HDAC4,0.0004390584625554,BrainAneurysm,ENSG00000068024,Tier 1,HDAC4,2,239969864.0,240323348.0,-1.0,histone deacetylase 4 [Source:HGNC Symbol;Acc:14063],0.0,1.0,1.0,1.0
819,819,ITGA2B,0.0004390584625554,AD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
819,819,ITGA2B,0.0004390584625554,PD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,1.0
829,829,SEMA3E,0.0004378740066682,UnipolarDepression,ENSG00000170381,Tier 3B,SEMA3E,7,82993222.0,83278326.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E [Source:HGNC Symbol;Acc:10727]",0.0,1.0,1.0,1.0
831,831,SEMA3C,0.0004378740066682,AD,ENSG00000075223,Tier 3A,SEMA3C,7,80371854.0,80551675.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [Source:HGNC Symbol;Acc:10725]",1.0,1.0,1.0,1.0
833,833,IAPP,0.0004367555788455,ProgressiveSupranuclearPalsy,ENSG00000121351,Tier 1,IAPP,12,21507893.0,21532912.0,1.0,islet amyloid polypeptide [Source:HGNC Symbol;Acc:5329],0.0,1.0,1.0,1.0
834,834,SPON1,0.0004367555788455,AD,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
838,838,TNFRSF25,0.0004350446021285,MS,ENSG00000215788,Tier 3A,TNFRSF25,1,6521211.0,6526255.0,-1.0,"tumor necrosis factor receptor superfamily, member 25 [Source:HGNC Symbol;Acc:11910]",0.0,1.0,1.0,1.0
842,842,ADCY2,0.0004338204363955,BipolarDisorder,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
842,842,ADCY2,0.0004338204363955,UnipolarDepression,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
843,843,CILK1,0.0004335731888428,PartialEpilepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
844,844,DYRK1A,0.0004335731888428,PD,ENSG00000157540,Tier 1,DYRK1A,21,38738092.0,38889753.0,1.0,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:3091],0.0,1.0,1.0,1.0
845,845,CHRM2,0.0004335731888428,MajorDepressiveDisorder,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,1.0
845,845,CHRM2,0.0004335731888428,UnipolarDepression,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,1.0
846,846,PSEN1,0.0004284279468102,AD,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,1.0,1.0
846,846,PSEN1,0.0004284279468102,FrontotemporalDementia,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,1.0,1.0
847,847,CHI3L1,0.0004284279468102,Schizophrenia,ENSG00000133048,Tier 3A,CHI3L1,1,203148059.0,203155877.0,-1.0,chitinase 3-like 1 (cartilage glycoprotein-39) [Source:HGNC Symbol;Acc:1932],0.0,1.0,1.0,1.0
848,848,SLC9A8,0.0004284279468102,ALS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
848,848,SLC9A8,0.0004284279468102,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
853,853,ILDR1,0.0004229047008411,MS,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
856,856,HCRT,0.000421242795876,NarcolepsyCataplexy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,1.0,1.0,1.0
856,856,HCRT,0.000421242795876,Narcolepsy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,1.0,1.0,1.0
865,865,TNFSF18,0.000421242795876,NarcolepsyCataplexy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
865,865,TNFSF18,0.000421242795876,Narcolepsy,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
872,872,IL7,0.0004168373845001,MS,ENSG00000104432,Tier 3A,IL7,8,79587978.0,79717758.0,-1.0,interleukin 7 [Source:HGNC Symbol;Acc:6023],0.0,1.0,1.0,1.0
875,875,AKT3,0.0004160165398302,AnorexiaNervosa,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
875,875,AKT3,0.0004160165398302,Schizophrenia,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,AnorexiaNervosa,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,BipolarDisorder,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,OCD,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,Schizophrenia,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,TouretteSyndrome,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
879,879,SRPK2,0.0004113727537413,UnipolarDepression,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,1.0,1.0
881,881,CDH11,0.0004031510358472,Schizophrenia,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25,0.25
889,889,LTBP3,0.000383341996137,UnipolarDepression,ENSG00000168056,Tier 3A,LTBP3,11,65306276.0,65326401.0,-1.0,latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:6716],3.0,1.0,1.0,1.0
896,896,VEGFC,0.0003731117201246,BrainAneurysm,ENSG00000150630,Tier 3B,VEGFC,4,177604689.0,177713881.0,-1.0,vascular endothelial growth factor C [Source:HGNC Symbol;Acc:12682],0.0,1.0,1.0,1.0
